Salmeterol/fluticasone of value for mild-to-moderate asthma
Mandatory folic acid fortification of flour: for and against
Reduction of NICE cost-effectiveness threshold recommended
Dibotermin-α delivers for fractures and spinal fusion
Impetus for developed countries to improve global health
High-dose fluconazole should reduce mortality at acceptable cost
Surgical staging good value for endometrial cancer
There is considerable regional variation in the prescribing of antibacterials for community-acquired pneumonia (CAP) across Germany,
Drug resistance surveillance of little value for ART sequencing
Alteplase cost saving following acute ischaemic stroke
Ertapenem less costly than piperacillin/tazobactam in foot infections
Children whose parents divorce have a greater risk of being prescribed methylphenidate,
The prescribing of sleep-related medications is "somewhat common" among child and adolescent inpatients,
HPV vaccination likely to be well worth it in Canada
The cost of outpatient epoetin and IV iron therapy for anaemia in patients with heart failure (HF) exceeds that of the resulting savings from reduced hospitalisations,
Use of psychotropics, especially antidepressants, among US adults has increased considerably since 1988−1994,
Painful, inflamed costs for patients with fibromyalgia
Sunitinib cost effective for renal cancer
NSAID prescriptions plunge following product withdrawal
Inhaled insulin satisfies patients with type I DM
The prevalence of epilepsy is higher among individuals of low socioeconomic status, and the treatment gap* is high,
Naproxen sodium/sumatriptan effective for migraines, improves QOL
Patients with comorbid bipolar disorder and post-traumatic stress disorder (PTSD) have a "more severe psychopathology", and may use more healthcare resources than those with either disorder alone,
A new institute for the evaluation of health programmes around the world has been launched by the University of Washington with support from the Gates Foundation.
Abbott's offer to supply lopinavir/ritonavir [Kaletra] at a per-patient cost of $US1000/year has been accepted by the Brazilian government.
A 2-year response plan to contain drug-resistant tuberculosis (TB) has been launched
Boehringer Ingelheim announced the shipment of its 1 millionth mother-child pair dose of nevirapine [Viramune] to Malawi.
A growing emphasis on preventative medicine in Europe is giving the personalised medicine and pharmacogenomics market greater impetus,
A massive study of the genetic and environmental causes of disease among US children will begin recruiting subjects in 2008,